Page last updated: 2024-09-04

lonafarnib and prodigiosin

lonafarnib has been researched along with prodigiosin in 1 studies

Compound Research Comparison

Studies (lonafarnib)	Trials (lonafarnib)	Recent Studies (post-2010) (lonafarnib)	Studies (prodigiosin)	Trials (prodigiosin)	Recent Studies (post-2010) (prodigiosin)
224	34	90	747	3	321

Protein Interaction Comparison

Protein	Taxonomy	lonafarnib (IC50)	prodigiosin (IC50)
Low molecular weight protein-tyrosine phosphatase A	Mycobacterium tuberculosis H37Rv		8.8

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ankri, S; Debnath, A; Rodriguez, MA	1

Other Studies

1 other study(ies) available for lonafarnib and prodigiosin

Article	Year
Editorial: Recent Progresses in Amebiasis. Frontiers in cellular and infection microbiology, 2019, Volume: 9 Topics: Amebicides; Anisomycin; Asymptomatic Diseases; Drug Discovery; Dysentery, Amebic; Entamoeba histolytica; Flavonoids; Gene Expression Regulation; Humans; Life Cycle Stages; Metabolic Networks and Pathways; Metronidazole; Piperidines; Prodigiosin; Protozoan Proteins; Pyridines; Severity of Illness Index	2019

Article

Year

Editorial: Recent Progresses in Amebiasis.

Frontiers in cellular and infection microbiology, 2019, Volume: 9

Topics: Amebicides; Anisomycin; Asymptomatic Diseases; Drug Discovery; Dysentery, Amebic; Entamoeba histolytica; Flavonoids; Gene Expression Regulation; Humans; Life Cycle Stages; Metabolic Networks and Pathways; Metronidazole; Piperidines; Prodigiosin; Protozoan Proteins; Pyridines; Severity of Illness Index

2019